drug development

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

drug development
Mar 22, 2024, 15:57 | Dialogues
OncoInfluencers: Dialogue with Lillian L. Siu, hosted by Gevorg Tamamyan
Join us for an exciting new episode of “OncoInfluencers”, hosted by Dr. Gevorg Tamamyan. In…
Mar 3, 2024, 16:42 | Blog
Vivek Subbiah: Thrilled to announce a groundbreaking - AstraZeneca and Sarah Cannon Docs collaboration
Vivek Subbiah shared a post on X: "Exciting News in Clinical Trials! Thrilled to announce…
Feb 26, 2024, 15:38 | Blog
ALADDIN Education: Applications for the ALADDIN Education 360° rotation with the European Medicines Agency are now open
ALADDIN Education posted on LinkedIn: "Interested in gaining practical experience in regulatory affairs and drug…
Feb 19, 2024, 18:18 | Blog
Anas Younes: We are developing more than one drug for the same disease indication, so we can build future combination regimens
Anas Younes posted on LinkedIn: ''Our hematology team spent the last 3 days reviewing our…
Feb 16, 2024, 05:40 | Blog
Justin Stebbing: You're all invited to an event about teamwork and collaboration at breakneck speed
Justin Stebbing shared a post on LinkedIn: "You're all invited to an event about teamwork and…
Feb 4, 2024, 22:50 | Blog
Tara Frenkl: Couldn't agree more that collaboration and teamwork are key
Tara Frenkl, Senior Vice President, Head of Oncology Development at Bayer, shared on LinkedIn: "Thanks…
Feb 1, 2024, 05:27 | Blog
Shweta Maniar: After attending the J.P. Morgan Healthcare Conference in San Francisco, I want to share some of my key takeaways
Shweta Maniar, Global Director, Healthcare and Life Sciences at Google, shared on their LinkedIn: ''After…
Jan 12, 2024, 17:31 | Blog
Karin Hoelzer: I was honored to represent the National Organization for Rare Disorders and the rare community in this important discussion
Karin Hoelzer, Director of Policy and Regulatory Affairs at NORD shared on LinkedIn: “Drug development…
Dec 19, 2023, 18:00 | Insight
Vivek Subbiah: The evolution of basket trials in cancer drug development
Vivek Subbiah shared on X/Twitter: "Revolutionizing cancer drug development: Harnessing the potential of basket trials…
Dec 12, 2023, 17:55 | Opinion
Isabel Mestres: Are we investing smartly?
Isabel Mestres, CEO at City Cancer Challenge Foundation, shared the following post on LinkedIn: ''Innovation…
Dec 10, 2023, 18:07 | Blog
Nathan Vardi: I traveled down to Maryland and spent the day at the FDA
Nathan Vardi, Managing Editor, Enterprise at MarketWatch, shared on LinkedIn: "Not long after my book, FOR…
Nov 27, 2023, 17:33 | Opinion
Rescuing drugs and the multi-stakeholder approach for drug development - ACCELERATE Multi-Stakeholder Platform
ACCELERATE Multi-Stakeholder Platform shared on their LinkedIn page: "Better therapies for childhood cancer remain an…
Jul 6, 2023, 04:38 | Blog
This WECAN Academy was just amazing, a very unique, patient-driven, cross-cancer training event with such amazing advocates from so many counties
In a post by Jan Geissler on Linkedin, it says, "The four days of the WECAN Academy…
Jun 25, 2023, 16:21 | Drugs
Are we entering a ‘golden age’? - Daniel Stover
Are we entering a ‘golden age’? -For discovery, drug development, & new treatments perhaps an…
12
All: 114 Posts: 101 - 200
Special Coverage